Literature DB >> 17176757

Incidence of lysogenic, colicinogenic and siderophore-producing strains among human non-pathogenic Escherichia coli.

J Smarda1, D Smajs, S Horynová.   

Abstract

The current incidence of Escherichia coli strains in healthy humans capable of producing the inhibitory exoproducts, such as temperate bacteriophages, corpuscular or HMW (high-molar mass) and proteinaceous or LMW (low-molar mass) colicins and siderophores was determined. Fifty-three E. coli strains were collected from the colons of 53 healthy human volunteers in Brno (Czechia) and tested for spontaneous and induced production of inhibitory exoproducts in a cross-test against each other. Of the strains tested, 37.7% produced bacteriophages, 41.5% produced from one to several LMW colicins, 11.3% formed HMW colicins and 15.1% (eight strains) produced exocellular siderophores different from enterochelin. Of these, seven strains formed aerobactin and one strain formed an untyped siderophore. E. coli strains differ greatly in the incidence of colicinogeny and lysogeny from its closest systemic relatives in the genus Escherichia and therefore should not be regarded as a model bacterium in this respect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176757     DOI: 10.1007/bf02931581

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  15 in total

1.  Three recently acknowledged Escherichia species strikingly differ in the incidence of bacteriocinogenic and lysogenic strains.

Authors:  Jan Smarda; David Smajs; Hana Lhotová
Journal:  J Basic Microbiol       Date:  2002       Impact factor: 2.281

2.  Incidence and manifestations of colicinogeny in strains of Escherichia coli.

Authors:  J SMARDA
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1960

3.  Incidence of colicinogenic strains among human Escherichia coli.

Authors:  J Smarda; V Obdrzálek
Journal:  J Basic Microbiol       Date:  2001       Impact factor: 2.281

4.  Electron microscopy of the anti-bacterial agent produced by Escherichia coli 15.

Authors:  H D Mennigmann
Journal:  J Gen Microbiol       Date:  1965-11

5.  Epidemiology of aerobactin production in Enterobacteriaceae.

Authors:  E Cercenado; F Baquero; A Delgado-Iribarren; J L Martínez
Journal:  Ann Inst Pasteur Microbiol       Date:  1986 Nov-Dec

6.  [Colicinogens in nonspecific intestinal inflammation. I. Colicinotypes in patients with ulcerous colitis, Crohn's disease and in healthy individuals].

Authors:  J Bures; V Horák; E Buresová; B Fixa; O Komárková
Journal:  Cesk Gastroenterol Vyz       Date:  1983-03

7.  Plasmid and chromosomal mutants in the iron(III)-aerobactin transport system of Escherichia coli. Use of streptonigrin for selection.

Authors:  V Braun; R Gross; W Köster; L Zimmermann
Journal:  Mol Gen Genet       Date:  1983

8.  Colicins produced by the Escherichia fergusonii strains closely resemble colicins encoded by Escherichia coli.

Authors:  David Smajs; Sandor E Karpathy; Jan Smarda; George M Weinstock
Journal:  FEMS Microbiol Lett       Date:  2002-03-05       Impact factor: 2.742

9.  The Yersinia high-pathogenicity island and iron-uptake systems in clinical isolates of Escherichia coli.

Authors:  Ryszard Koczura; Adam Kaznowski
Journal:  J Med Microbiol       Date:  2003-08       Impact factor: 2.472

10.  The early postnatal development of salivary antibody and immunoglobulin response in children orally colonized with a nonpathogenic, probiotic strain of E. coli.

Authors:  Z Vancíková; R Lodinová-Zádníková; J Radl; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

View more
  7 in total

1.  Occurrence of strains producing specific antibacterial inhibitory agents in five genera of Enterobacteriaceae.

Authors:  Jan Smarda; David Smajs; Hana Lhotová; Daniela Dedicová
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

2.  Novel colicin Fy of Yersinia frederiksenii inhibits pathogenic Yersinia strains via YiuR-mediated reception, TonB import, and cell membrane pore formation.

Authors:  Juraj Bosák; Petra Laiblová; Jan Smarda; Daniela Dedicová; David Smajs
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

3.  Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.

Authors:  David Smajs; Jan Bureš; Jan Smarda; Eva Chaloupková; Jaroslav Květina; Miroslav Förstl; Darina Kohoutová; Martin Kuneš; Stanislav Rejchrt; Jiřina Lesná; Marcela Kopáčová
Journal:  Curr Microbiol       Date:  2011-11-25       Impact factor: 2.188

4.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

6.  Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible.

Authors:  Juraj Bosák; Lenka Micenková; Martin Vrba; Alena Ševčíková; Daniela Dědičová; Debora Garzetti; David Šmajs
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

7.  Novel Temperate Phages of Salmonella enterica subsp. salamae and subsp. diarizonae and Their Activity against Pathogenic S. enterica subsp. enterica Isolates.

Authors:  Lenka Mikalová; Juraj Bosák; Hana Hříbková; Daniela Dědičová; Oldřich Benada; Jan Šmarda; David Šmajs
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.